Skip to content

Auscultatory characteristics of novel coronavirus pneumonia (COVID-19)

Auscultatory characteristics of novel coronavirus pneumonia (COVID-19)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030722
Enrollment
Unknown
Registered
2020-03-12
Start date
2020-03-09
Completion date
Unknown
Last updated
2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Case series:Nil

Sponsors

Shanghai First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. over 18 years old; 2. Patients diagnosed with Covid-19 pneumonia (those who meet the clinical diagnosis above the common type or have a positive nucleic acid test); 3. Have 64-row high-resolution CT examination of the chest within 24 hours; 4. There is no clear history of other cardiopulmonary diseases (such as with COPD, massive pleural effusion, tuberculosis, pulmonary hypertension, severe heart failure, pulmonary heart disease, etc.); 5. Able to cooperate with lung auscultation and agree to participate in the examination; 6. Be able to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Investigator believes that subjects should not be included (patients are severely uncooperative); 2. Not suitable for inclusion in subjects (clinically considered fully healthy patients or light); 3. Patients who cannot auscultate clearly with non-invasive or invasive ventilation (patients who can still auscultate are not excluded); 4. Pregnant women and children.

Design outcomes

Primary

MeasureTime frame
ascultation;

Secondary

MeasureTime frame
CT imaging;clinical characteristics;

Countries

China

Contacts

Public ContactZhi Zhang

Shanghai First People's Hospital

16683890@qq.com+86 13621759762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026